<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="antiviral1\PMC6963560\results\search\drugs\results.xml">
  <result pre="by several authors; (3) An additional choice is given by" exact="rituximab" post="(RTX), which selectively targets B cells and causes depletion"/>
  <result pre="by HCV should be treated first with immunosuppressive agents (with" exact="rituximab" post="as first-line agent) with or without plasma exchange. Current"/>
  <result pre="production and cryoglobulins. Two RCTs have demonstrated the superiority of" exact="rituximab" post="mono-therapy as compared with conventional immunosuppressive therapy (i.e., corticosteroids,"/>
  <result pre="individuals also received intravenous therapy with corticosteroids (500 mg/day of" exact="methylprednisolone" post="for three consecutive days). No additional immunosuppressive medications or"/>
  <result pre="mixed cryoglobulinemia with sofosbuvir-based direct-acting antiviral agentsHepatology20166340841710.1002/hep.2829726474537 23.SaadounD.ThibaultV.AhmedS.N.S.AlricL.MalletM.GuillaudC.IzzedineH.PlaisierA.FontaineH.CostopoulosM.et al.Sofosbuvir plus" exact="ribavirin" post="for hepatitis C-associated cryoglobulinaemia vasculitis: Vascuvaldic studyAnn. Rheum. Dis.2016751777178210.1136/annrheumdis-2015-20833926567178"/>
  <result pre="cryoglobulinemiaAm. J. Gastroenterol.20171121298130810.1038/ajg.2017.4928291241 26.SaadounD.PolS.FerfarY.AlricL.HezodeC.AhmedS.N.S.de Saint MartinL.ComarmondC.BouyerA.S.MussetL.et al.Efficacy and safety of" exact="sofosbuvir" post="plus daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitisGastroenterology2017153495210.1053/j.gastro.2017.03.00628288791 27.BonacciM.LensS.MariñoZ.LondoñoM.C.Rodriguez-TajesS.Sánchez-TapiasJ.M.Ramos-CasalsM.Hernández-RodríguezJ.FornsX.Long-term"/>
  <result pre="Gastroenterol.20171121298130810.1038/ajg.2017.4928291241 26.SaadounD.PolS.FerfarY.AlricL.HezodeC.AhmedS.N.S.de Saint MartinL.ComarmondC.BouyerA.S.MussetL.et al.Efficacy and safety of sofosbuvir plus" exact="daclatasvir" post="for treatment of HCV-associated cryoglobulinemia vasculitisGastroenterology2017153495210.1053/j.gastro.2017.03.00628288791 27.BonacciM.LensS.MariñoZ.LondoñoM.C.Rodriguez-TajesS.Sánchez-TapiasJ.M.Ramos-CasalsM.Hernández-RodríguezJ.FornsX.Long-term outcomes of"/>
  <result pre="31.Zarębska-MichalukD.StępieńP.M.PaluchK.PabjanP.Retreatment of symptomatic HCV genotype 3 associated mixed cryoglobulinemia with" exact="sofosbuvir" post="plus ribavirin: A case reportClin. Exp. Hepatol.2018410010329904727 32.ElmowafyA.Y.El MaghrabiH.M.ZahabM.A.ElwasifS.M.BakrM.A.Sofosbuvir"/>
  <result pre="plus ribavirin: A case reportClin. Exp. Hepatol.2018410010329904727 32.ElmowafyA.Y.El MaghrabiH.M.ZahabM.A.ElwasifS.M.BakrM.A.Sofosbuvir and" exact="daclatasvir" post="in treatment of HCV-related membranoproliferative glomerulonephritis with cryoglobulinemia in"/>
  <result pre="direct-acting antiviralsIndian J. Nephrol.20182846246430647501 34.ChiaX.X.CherepanoffS.DantaM.FurlongT.Successful treatment of HCV-related glomerulonephritis with" exact="sofosbuvir" post="and daclatasvirNephrology2018333738010.1111/nep.1308729520905 35.De VitaS.QuartuccioL.IsolaM.MazzaroC.ScainiP.LenziM.CampaniniM.NaclerioC.TavoniA.PietrograndeM.et al.A randomized controlled trial of"/>
  <result pre="sofosbuvir and daclatasvirNephrology2018333738010.1111/nep.1308729520905 35.De VitaS.QuartuccioL.IsolaM.MazzaroC.ScainiP.LenziM.CampaniniM.NaclerioC.TavoniA.PietrograndeM.et al.A randomized controlled trial of" exact="rituximab" post="for the treatment of severe cryoglobulinemic vasculitisArthritis Rheum.20126484385310.1002/art.3433122147661 36.SnellerM.HuZ.LangfordC.A"/>
  <result pre="of severe cryoglobulinemic vasculitisArthritis Rheum.20126484385310.1002/art.3433122147661 36.SnellerM.HuZ.LangfordC.A randomized controlled trial of" exact="rituximab" post="following failure of antiviral therapy for hepatitis C virus"/>
  <result pre="antibodies and direct antiviral agentsOncotarget20178417644177710.18632/oncotarget.1698628454112 38.RoccatelloD.SciasciaS.BaldovinoS.RossiD.AlpaM.NarettoC.Di SimoneD.MenegattiE.Improved (4 plus 2)" exact="rituximab" post="protocol for severe cases of mixed cryoglobulinaemia: A 6-year"/>
  <result pre="observational studyAm. J. Nephrol.20164325126010.1159/00044584127161362 39.TerrierB.LaunayD.KaplanskiG.HotA.LarrocheC.CathébrasP.CombeB.De JaureguiberryJ.P.MeyerO.SchaeverbekeT.et al.Safety and efficacy of" exact="rituximab" post="in nonviral cryoglobulinemia vasculitis, data from the French Autoimmunity"/>
  <result pre="two casesWorld J. Clin. Cases2015373674210.12998/wjcc.v3.i8.73626301235 41.FabriziF.MartinP.ElliA.MontagninoG.BanfiG.PasseriniP.CampiseM.R.TarantinoA.PonticelliC.Hepatitis C virus infection and" exact="rituximab" post="therapy after renal transplantationInt. J. Artif. Organs20073044544910.1177/03913988070300051317551909 42.HamzehM.HosseinimehrS.J.KhalatbaryA.R.MohammadiH.R.DashtiA.AmiriF.T.Atorvastatin mitigates"/>
 </snippets>
</snippetsTree>
